![Quiver Logo](/static/img/logo-icon.png)
![CNTB logo](https://quiver-logos.s3.us-east-2.amazonaws.com/cntb.png)
Connect Biopharma Holdings Limited American Depositary Shares
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view CNTB Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of CNTB by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CNTB's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to CNTB
Recent picks made for CNTB stock on CNBC
ETFs with the largest estimated holdings in CNTB
Flights by private jets registered to CNTB
![Quiver Logo](/static/img/logo-icon.png)